Acadian Asset Management LLC Yumanity Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.5 - $1.87 $24,402 - $30,421	-16,268 Reduced 57.9%	11,831 $18,000
Q2 2022 Aug 09, 2022	SELL	$1.02 - $1.99 $34,543 - $67,393	-33,866 Reduced 54.65%	28,099 $52,000
Q1 2022 May 12, 2022	SELL	$0.97 - $3.27 $13,544 - $45,659	-13,963 Reduced 18.39%	61,965 $91,000
Q4 2021 Feb 10, 2022	BUY	$2.81 - $10.48 $156,115 - $582,237	55,557 Added 272.73%	75,928 $223,000
Q3 2021 Nov 12, 2021	SELL	$8.3 - $12.04 $90,328 - $131,031	-10,883 Reduced 34.82%	20,371 $210,000

Q2 2021 Aug 11, 2021	BUY	$11.27 - $19.64 $352,232 - $613,828	31,254 New	31,254 $364,000
Q1 2021 May 11, 2021	SELL	$16.69 - $22.52 $216,619 - $292,287	-12,979 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$16.67 - $25.4 $216,359 - $329,666	12,979 New	12,979 $221,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.